Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATRA, Celecoxib, and Itraconazole Maintenance Post-Autologous Transplant in Relapsed Multiple Myeloma
NCT02401295Phase 1Completed
- Sponsor
- University of Iowa
- Start
- May 2015
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tretinoin, celecoxib and itraconazole in multiple myeloma (MM), sponsored by University of Iowa. Primary endpoint: Number of Participants with Adverse Events at 6 months. Started May 2015; status: completed.
02
Drugs
tretinoincelecoxibitraconazole
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT02401295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02401295.